The world's second-largest economy, with thousands of companies listed in Shanghai and Shenzhen. Strong in banking, manufacturing, consumer brands and fast-growing tech, though heavily shaped by government policy.
Index·
Why is China moving?
Q3 2026
▲2▼1
AI tech boom lifts China stocks, but growth and trade risks weigh
▲
AI-driven tech boom China's tech sector surged as chip, memory, optical, and server companies reported profit jumps. Huawei's AI computing advances and ChangXin's IPO boosted confidence, while Nvidia H200 shipments eased supply constraints.
This was the main positive force lifting China markets in Q3.
▲
Broad market support Biotech, lithium, and EV exports gained, supported by share buybacks and state support. These factors lifted sentiment beyond the tech sector, helping to broaden the market rally.
It shows the positive drivers were not limited to tech, giving a fuller picture.
▼
Economic and trade headwinds Weak 4.3% GDP growth, record household loan defaults, foreign downgrades, and new US tariffs and export bans on transceivers, robots, drones, solar equipment, and CXMT memory pressured exporters. Solar overcapacity caused heavy losses.
These were the major negative forces weighing on China markets during the quarter.
◆
Late-quarter uncertainties OpenAI and Anthropic warned of an AI slowdown, Beijing's possible Nvidia purchases threatened domestic chipmakers, and BYD's sales fell amid price wars. Vanke needed regulatory shielding, while GAC-FAW consolidation carried execution risk.
These late developments added uncertainty and tempered the earlier optimism.
Latest
▲2▼1
AI chip demand wobbles, biotech deals surge, Hong Kong listings boom
▼
OpenAI training pause hits AI chip demand outlook OpenAI paused training its most advanced models after a security incident, triggering a sell-off in Asian chip stocks. Cambricon fell 5.7%, SMIC 3.6%, NAURA 3.3%, and Luxshare 4.9%. This raises doubts about whether the AI infrastructure spending boom that has driven China's chip and hardware shares can keep growing at the same pace.
This is the biggest new negative force this period, directly hitting the AI chip demand story that has driven China's tech rally.
▲
Biotech licensing deals keep rolling in Dizal received $600 million upfront from AstraZeneca, AstraZeneca invested $2 billion in Summit, and Novartis signed a $7.8 billion RNA deal with Abogen. These deals bring cash into Chinese drug developers and validate their research, lifting biotech shares and encouraging more investment in the sector.
A steady stream of large global pharma deals is a major new positive force for China's biotech sector and broader market sentiment.
▲
Hong Kong share sales hit record on AI fundraising Hong Kong raised a record $47.5 billion in Q3 share sales, led by Alibaba's $10.2 billion offering and Zhongji Innolight's nearly $8 billion listing. This shows deep investor appetite for Chinese AI and tech companies, giving them capital to expand and reinforcing Hong Kong's role as a fundraising hub.
Record fundraising is a clear signal of capital flowing into China's tech sector and supports the AI growth story.
◆
China halts fuel exports, lifting oil prices but squeezing refiners China ordered refineries to stop exporting diesel, gasoline and jet fuel in October to preserve domestic reserves. Global oil prices jumped over 1%, and Asian refining margins rose. This supports oil prices and energy shares but may hurt Chinese refiners' export revenue and adds to global fuel tightness.
This is a new policy move with clear market impact on energy prices and refining margins, affecting China's energy sector.
News movingChina
SwitzerlandChina
China▲impact 4
Novartis Signs $7.8B RNA Therapeutics Deal With Abogen Biosciences
Novartis entered a licensing and option agreement with China-based Abogen Biosciences, giving the Swiss pharma giant exclusive worldwide rights to Abogen's lead candidate ABO2203 and options to license additional programs built on Abogen's proprietary RNA platform. Under the agreement, Abogen will receive an upfront payment of $575 million and is eligible to receive up to approximately $7.2 billion in potential milestone payments if all options covering additional programs are exercised and the specified development, regulatory and commercial milestones are achieved, plus royalties on future product sales. ABO2203 is an investigational messenger RNA-encoded CD19xCD3 T-cell engager being developed for autoimmune diseases, designed to reset B cells by directing endogenous production of T-cell engagers in vivo. The transaction remains subject to customary closing conditions, including required regulatory clearances. The deal comes as Novartis faces generic competition for Entresto and Promacta and back-to-back pipeline setbacks, including the late-stage failure of pelacarsen and the HARBOR study of del-desiran in myotonic dystrophy type 1.
Biotech & Genomic Medicine › RNA Therapeutics ▲Capital
Biotech & Genomic Medicine › mRNA Platforms ▲Capital
NOVN.SW · Capital · Positive Novartis signs $7.8B licensing/option deal with Abogen for RNA therapeutics, adding pipeline assets amid generic competition and pipeline setbacks
Abogen Biosciences · Capital · Positive Abogen receives $575M upfront and up to ~$7.2B in milestones plus royalties under the Novartis licensing and option agreement
Tesla Q3 Deliveries Beat Estimates, On Track to End Two-Year Decline
Tesla delivered 486,532 vehicles in the third quarter of 2026, beating the Zacks Consensus Estimate of 471,262 units, with deliveries up 1.3% sequentially but down 2.1% year over year. Through the first nine months of 2026, Tesla delivered 1,324,681 vehicles and needs just more than 311,448 units in the fourth quarter to break its streak of annual declines. The competitive picture remains concerning, as BYD sold 762,478 passenger battery-electric vehicles in the quarter, up roughly 31% year over year, while NIO delivered 109,178 vehicles, up 25.4% year over year. In the last reported quarter, automotive gross margin excluding regulatory credits slipped to 16.3%, and energy storage margins fell to 20.4% from 39.5%, while Tesla expects capital spending above $25 billion in 2026. Tesla's robotaxi network had covered roughly 380,000 driverless miles, compared with Waymo's more than 220 million rider-only miles, and the company recently moved its Roadster demonstration from Oct. 1 to Oct. 15. Tesla's Oct. 21 earnings report is much-awaited, and TSLA stock currently carries a Zacks Rank #4 (Sell).
Bloomberg Intelligence: US AI Lead Over China Narrows to 3%
The US lead over China in artificial intelligence has narrowed to just 3%, according to new benchmarking data from Bloomberg Intelligence. That edge stood at 9% in May and 15% earlier this year, meaning the gap is closing very quickly. Much of China's progress comes from open weight models that are cheaper to produce and freely accessible, unlike the closed weight models from US companies such as Anthropic and OpenAI. The administration's hope has been that cutting off China's access to Nvidia's best chips would preserve the US advantage, but the silicon is already cut off and Chinese labs are still advancing rapidly. Meanwhile, Nvidia-backed US startup Reflection is pitching its open weight model as a domestic alternative for companies that want to build custom AI without relying on Chinese-based models.
Artificial Intelligence › AI Compute & Accelerator Silicon Competition
Reflection AI · Competition · Positive Nvidia-backed Reflection is pitching its open weight model as a domestic alternative for companies wanting custom AI without relying on Chinese-based models.
NVDA · Competition · Negative US AI lead over China narrows to 3% as Chinese labs advance despite Nvidia's best chips being cut off, and Reflection pitches an open-weight domestic alternative to Chinese models.
ADM Sees China's 25 Million Ton Soybean Commitment Boosting Ag Services
Archer Daniels Midland Company's Ag Services business stands to gain from continued Chinese purchases of U.S. soybeans, which would support grain merchandising, origination and transportation volumes. ADM's second-quarter 2026 Ag Services operating profit surged 159% year over year, helped by strong commercial execution and the return of its Barcarena, Brazil, export terminal to full operations. Management said China is well underway in fulfilling its commitment to purchase 25 million tons of U.S. soybeans in 2026 and has been buying roughly 1 million tons per week, a contributor to the company's 2026 outlook. ADM expects Ag Services results in the third quarter to be slightly lower than the second quarter, with fourth-quarter performance depending partly on the pace of U.S. exports and whether additional corn and sorghum programs develop alongside soybean shipments. The Zacks Consensus Estimate for ADM's 2026 and 2027 earnings per share indicates year-over-year growth of 59.2% and 3.9%, respectively, and the stock carries a Zacks Rank #1 (Strong Buy).
ADM · Demand · Positive China's 25 million ton U.S. soybean purchase commitment and ~1 million tons/week buying support ADM's grain merchandising, origination and transportation volumes.
Hirundo Releases Westernized Qwen, Cutting CCP-Aligned Answers From 89.8% to 2.8%
Hirundo, an AI safety lab specializing in machine unlearning, released Westernized versions of Alibaba's Qwen open-weight models with Chinese Communist Party political alignment removed directly from the model weights. On Hirundo's evaluation, the original Qwen3.6-35B-A3B produced CCP-aligned censorship, propaganda-aligned framing or political bias in 89.8% of responses across a 500-prompt benchmark, while the Westernized model did so in 2.8%, with reasoning, coding and instruction-following performance essentially unchanged. The reduction held on two external benchmarks, with refusals on DECCP falling from 65.26% to 3.16% and non-compliance on ChinaBench falling from 96.67% to 6.67%, and the same method cut CCP-aligned responses in the much smaller Qwen3.5-4B from 89.2% to 1.2%. On GPQA, IFBench, LiveCodeBench and MMLU-Pro, the Westernized model's scores stayed within 0.72 points of the original model's on average, and its safety and harmfulness benchmark scores also held. Both models are available now on Hugging Face as Qwen3.6-35B-A3B-Westernized and Qwen3.5-4B-Westernized, and Hirundo intends to release its CCPC-500 benchmark publicly.
Artificial Intelligence › Foundation Models & Research Labs Technology
Artificial Intelligence › Open-Weight Model Developers Technology
Cybersecurity & Digital Trust › AI Security & Agent Guardrails Technology
Artificial Intelligence › AI Tooling, Data & MLOps Technology
Hirundo · Technology · Positive Hirundo released its Westernized Qwen models and plans to publish its CCPC-500 benchmark, showcasing its machine-unlearning technology
9988.HK · Technology · Negative Hirundo released Westernized versions of Alibaba's Qwen models with CCP alignment stripped from the weights, undermining Alibaba's model positioning
IMF says innovation and consumption are driving China's new economy
Krishna Srinivasan, director of the Asia and Pacific Department at the International Monetary Fund, said in an interview with Xinhua Finance that China's shift toward a consumption-driven growth model supported by innovation could reinforce its medium-term growth trend and benefit the global economy. Srinivasan said China gives top priority to research and development, advanced manufacturing and innovation, with R&D spending second only to the United States and the most patent filings in the world. The 15th Five-Year Plan for National Economic and Social Development, covering 2026 to 2030, focuses on innovation, technological self-reliance and new quality productive forces. IMF research indicates that artificial intelligence technology could boost growth in emerging market economies by 0.2 to 0.8 percent, although the benefits remain uncertain and may be distributed unevenly. He stressed the need for policies to disseminate artificial intelligence technology, develop skills, adapt labor markets, protect social welfare and ensure AI governance, noting that this transition requires stronger social safety nets, structural reform of finance and fiscal policy, and adjustments to incentives that have long aimed at generating growth. On regional impact, data show that Asia accounts for about two-thirds of global economic growth, with China contributing about 30 percent, and the IMF expects that every 1 percentage point increase in China's growth will be associated with about a 0.3 percentage point increase in growth for other Asian countries over the medium term, especially those with strong trade links to China such as Vietnam and South Korea. The IMF also estimates that reducing non-tariff trade barriers in a legally binding form consistent with World Trade Organization principles would raise Asia's real gross domestic product by 1.8 percent over the medium to long term, with ASEAN economies benefiting especially. Srinivasan also spoke about the IMF's International Finance Research Center in Shanghai, the fund's only research center outside Washington, D.C., saying it focuses on studying emerging market and middle-income economies, not just China. Since it opened last December, the center has established a research steering committee and expanded its team of economists, research analysts and visiting scholars. The China-IMF Capacity Development Center based at the same site helps translate research into practice through capacity building and peer learning.
Chinese mutual funds close at highest rate in 8 years, expected to top 300 funds by year-end
Chinese mutual funds are shutting down at the fastest pace in eight years, after a weak Chinese stock market, a lack of new capital inflows, and continuous investor redemptions. Data compiled by Bloomberg shows that 256 publicly offered funds have been liquidated this year, and another 46 have warned investors that they may soon close, making it possible that more than 300 funds will shut down by the end of this year. If that happens, it would be the highest number since 2018, when fund closures hit a record high after a major industry reform forced many funds to cease operations. China's securities regulations require fund managers to report remedial plans, such as fund liquidation, to regulators if a fund's net assets stay below 50 million yuan, or 7.5 million dollars, for 60 consecutive trading days. Most of the funds that closed this year fell into that category. Meanwhile, the China Securities Index Active Equity Fund Index has posted an average annual return of negative 0.8% over the past five years, even though it has risen 3.6% this year. The CSI 300 has already fallen 6% in 2026, while the Star 50 index, which is dominated by chip stocks, has trimmed its gain to 14%. Chen Junde, a fund manager at Guangdong Fund Investment, said funds that are too small, have too few investors, or consistently underperform their benchmarks face high operating costs and struggle to justify continuing operations.
Niu Technologies Q3 2026 Sales Volume Rises 15.4% to 537,457 Units
Niu Technologies delivered 537,457 units in the third quarter of 2026, a 15.4% increase from 465,873 units in the prior-year period. The quarter lifted year-to-date sales volume to 1.23M units, up from 1.02M units in the first nine months of 2025 across its lineup of e-motorcycles, e-mopeds, e-bicycles, e-bikes, and kick-scooters. Domestic sales in China expanded 9% year-over-year to 490.41K units in the third quarter compared to 451.46K units in 3Q 2025, bringing year-to-date domestic volume to 1.14M units, with the N, M, and F series remaining top sellers across the region. International markets were the standout growth driver, with unit sales surging over 226% year-over-year to 47.05K units from 14.42K units in 3Q 2025, bringing year-to-date international volume to 93.22K units. The company also said its NIU AIOS platform received the Red Dot Award for its AI features and user experience, and it plans to continue embedding these connected technologies across future product lines.
Qualcomm and Huawei Sign Multi-Year 5G, AI Patent Licensing Deal
Qualcomm and Huawei have reached a multi-year, broad patent licensing agreement covering 5G, computing, AI and networking technologies. The deal includes cross-licenses to their respective patent portfolios, and Qualcomm will also purchase certain Huawei U.S. patents covering computing, AI, networking and other technologies. The transaction remains subject to regulatory approvals. Huawei said its intellectual-property licensing business has generated positive revenue since 2021, reflecting sustained investment in R&D, and that it held more than 165,000 active granted patents at the end of 2025. The two companies previously settled a patent dispute in 2020, when Huawei agreed to pay Qualcomm $1.8B in back licensing fees.
QCOM · Regulation · Positive Qualcomm signs a multi-year 5G/AI patent cross-license with Huawei and will buy certain Huawei US patents, subject to regulatory approvals.
Huawei · Regulation · Positive Huawei secures a multi-year cross-license with Qualcomm and sells certain US patents, with its IP licensing business generating positive revenue since 2021.
China reports continued consumption growth during National Day holiday, trade-in program generates 1.96 billion yuan in sales
China's Ministry of Commerce reported that customer traffic and revenue at 78 key shopping streets and commercial districts monitored by the ministry rose 3.4% and 5.3% year on year during the first three days of China's seven-day National Day holiday, which runs from October 1 to 7. The report said the Chinese government's consumer goods trade-in program generated 1.96 billion yuan in sales during the first three days of the holiday, equivalent to about 9.81 billion baht, benefiting 3.48 million consumers. Xinhua News Agency reported that the program brought about the trade-in of 46,000 vehicles, generating 7.45 billion yuan in new car sales, or about 37.2 billion baht; 1.51 million home appliances worth 6.5 billion yuan, or about 32.5 billion baht; and 1.71 million digital and smart devices worth 4.9 billion yuan, or about 24.5 billion baht. Meanwhile, Chinese authorities expect cross-regional passenger trips during the seven days to reach 2.13 billion, or an average of 300 million per day, with railway passenger trips on October 1 alone hitting 25.2 million, a record high for a single day. The Ministry of Culture and Tourism has also carried out a one-month national tourism promotion program since late September, with local governments holding more than 20,000 events and distributing vouchers and consumer subsidies worth about 310 million yuan, or roughly 1.55 billion baht, to boost tourism consumption.
China closes more than 670 banks in 2025, leaving 3,139, down 23% in four years
China is pressing ahead with the consolidation of its regional banks. In 2025 alone, more than 670 financial and banking entities were closed, a record high, and nearly all of them were in rural areas. As a result, the number of banking entities fell to 3,139 at the end of 2025, a decline of 23% over four years. A report by Fitch, citing data from China's National Financial Regulatory Administration, or NFRA, said China's small banks, most of them rural and city-level lenders, remain the weakest part of the system, weighed down by asset-quality problems, weak capital and regulatory shortcomings. Rural and regional city banks together account for more than a quarter of the assets in China's banking system. Jason Bedford, a senior researcher at the East Asian Institute of the National University of Singapore, believes the consolidation simplifies regulation and limits the liquidity risks of small financial institutions, adding that he has never seen consolidation on this scale. In July, authorities in the city of Wuhan took control of Z-Bank, which held 124 billion yuan in assets at the end of 2024, before merging it with Hankou Bank. It was the first bank takeover since the seizure of Baoshang Bank in Inner Mongolia in 2019. Moody's expects the mergers and acquisitions to continue.
MagPro launches AeroLev 1850 magnetic-bearing air-cooled chiller for AI data centers
MagPro, also known as Nanjing Xipu Technology Co., Ltd., a joint venture between CIGU Technology Corp. Ltd. and EPG Data Technology (Shanghai) Co., Ltd., announced the launch of the AeroLev 1850, a 1.85-megawatt magnetic-bearing air-cooled chiller platform that supports operation at temperatures up to 45°C and is designed for AI data centers in markets with hot, humid climates and limited water resources, such as Thailand. At its core is an air-cooled magnetic-bearing compressor with an isentropic efficiency of up to 87%, while a patented condenser increases refrigerant subcooling by more than 3°C. These technologies improve overall energy efficiency by up to 40%, reduce failure rates by up to 8% compared with conventional oil-lubricated compressors, and cut maintenance costs by up to 10% compared with traditional chillers. General Manager William Wu said that as AI drives rising demand for computing power, operators need cooling infrastructure that can scale without increasing dependence on water resources. Alik Wan, founder and chairman of EPG Data Technology (Shanghai) Co., Ltd., said MagPro is a significant step in the company's global cooling technology strategy.
UK New Car Sales Rise 12% in September, Driven by EVs and Chinese Brands
The UK new car market recorded its best September since 2017, with registrations up 12% year-on-year to 350,518 units, according to figures released on the 2nd by the Society of Motor Manufacturers and Traders. Supported by strong demand for electric vehicles, battery electric vehicle registrations in September rose 36% year-on-year to 99,199 units, taking a market share of 28.3%. In contrast, petrol car registrations fell 6.7% and hybrid vehicle registrations fell 4.2%. Diesel car registrations rose 11.5% in September, but were down 7% over the January-September period compared with a year earlier, with their market share shrinking to about 4.5% this year. By brand, the Jaecoo 7 SUV from China's Chery was the best-selling model, while among battery electric vehicles the Sealion 7 SUV from China's BYD ranked third, behind US EV giant Tesla's Model 3 sedan and Model Y SUV. On a year-to-date basis, battery electric vehicles account for only 26.2% of total sales, well below the 33% mandated for 2026 and also short of last year's 28% target.
Japanese firms in China fall to record-low 10,118, with 4,137 exits in two years
The number of Japanese companies operating in China has fallen to just 10,118 as of June 2026, the lowest since record-keeping began in 2010 and down 22% from the previous survey in June 2024, according to data from Teikoku Databank, a Japanese credit research firm. Compared with the peak in 2012, the number of Japanese companies in China has now dropped by roughly 30%. Over the past two years, as many as 4,137 Japanese companies withdrew from China entirely, a record high, while only 1,221 Japanese companies entered the Chinese market through setting up subsidiaries, factories or representative offices during the same period, the lowest on record excluding the COVID-19 pandemic period. Jeremy Chan, an analyst at Eurasia Group, said many Japanese companies had already planned to scale down their operations in China, but the rapid deterioration in China-Japan relations has led many to consider exiting the Chinese market with greater urgency. Tensions flared after Japanese Prime Minister Sanae Takaichi told parliament in November 2025 that Japan could become militarily involved if China used force to invade Taiwan, and Beijing responded by restricting exports of certain critical minerals to Japanese companies and urging Chinese citizens to avoid travel to Japan. Jesper Koll, an expert at Monex Group, noted that companies listed on the TOPIX index have seen the share of their profits coming from China fall to below 15% this year, from about 23% in 2020. Conversely, the share of profits coming from the U.S. market rose to about 35% from 25% over the same period.
Teikoku Databank, Ltd. · · Neutral Teikoku Databank is cited as the data source for the record-low count of Japanese firms in China; no impact on its own business.
First Chinese auto show held in Argentina as Chinese brands' sales share surges from 2% to 10%
Argentina's first Chinese auto show opened on the 2nd in the capital, Buenos Aires. Under President Milei, the country's auto market is shifting from strong protectionism toward a more open and competitive environment. Helped by a measure allowing up to 50,000 electric and hybrid vehicles to be imported duty-free in 2026, Chinese brands have been entering the market one after another, and in August the Chinese brands' share of passenger car and light commercial vehicle sales reached 10%, up from about 2% in late 2025. Chinese electric vehicle giant BYD has become the ninth-largest auto brand by sales since entering Argentina in late 2025. More than 20 Chinese brands exhibited at the auto show, including Geely, Chery, Great Wall Motor and Dongfeng Motor, and Sebastian Beato, president of the Argentine auto dealers association, said the remarkable growth of Chinese brands is prompting the domestic auto industry to produce new models.
Electrification & Mobility › China NEV Leaders ▲Competition
002594.CS · Demand · Positive BYD became Argentina's ninth-largest auto brand by sales since entering in late 2025, with Chinese brands' share reaching 10%.
0175.HK · Demand · Positive Geely exhibited at Argentina's first Chinese auto show as Chinese brands' sales share surged to 10% on duty-free EV import measure.
601633.CG · Demand · Positive Great Wall Motor exhibited at Argentina's first Chinese auto show as Chinese brands' sales share surged to 10%.
9973.HK · Demand · Positive Chery exhibited at Argentina's first Chinese auto show amid Chinese brands' sales share rising from 2% to 10%.
NIO Q3 Deliveries Hit 109,178 as Growth Slows to 25.4%
NIO Inc. reported third quarter 2026 deliveries of 109,178 vehicles, landing inside its September 1 guidance range of 108,000 to 111,000 vehicles, alongside guided revenue of RMB 33,285 million to RMB 34,051 million. September deliveries came in at 37,408 vehicles, bringing 2026 year-to-date deliveries to 300,301 and cumulative deliveries to about 1.30 billion as of September 30, 2026. Deliveries grew year over year across NIO, ONVO and FIREFLY, but the third quarter growth rate slowed to 25.4% from faster rates earlier in 2026, pointing to moderating operational momentum. The company's narrative projects CN¥174.7 billion in revenue and CN¥4.0 billion in earnings by 2029, with a fair value estimate of $6.38, while more optimistic analysts had assumed roughly 37.7% annual revenue growth and about CN¥11.7 billion in earnings. The moderated pace puts near-term pressure on the key catalyst of margin improvement and progress toward breakeven, and sharpens the risk that intense Chinese EV competition could keep pricing and profitability under strain.
Electrification & Mobility › China NEV Leaders ▼Demand
9866.HK · Demand · Negative Q3 deliveries of 109,178 grew only 25.4% year over year, a slowdown pointing to moderating operational momentum and pressure on margin improvement.
Daqo New Energy Fair Value Cut 18% as JPMorgan and Goldman Split on Rating
Daqo New Energy's fair value estimate has been trimmed from about US$23.95 to about US$19.65, an adjustment of roughly 18%, as analysts remain sharply divided on the stock. JPMorgan maintains an Overweight rating with a revised US$22 price target, still above the updated fair value estimate, while Goldman Sachs shifted to a Sell rating with a reduced US$10 target, citing a Q2 non GAAP net loss driven by lower recognized average selling prices and higher SG&A expenses. The company issued new production guidance for the third quarter of 2026 targeting polysilicon output of about 40,000 MT to 45,000 MT, and for the full year 2026 guided to polysilicon production of about 160,000 MT to 180,000 MT, including the impact of annual facility maintenance. Daqo New Energy was also removed from the FTSE All World Index in US$ terms, and Reuters reported that the U.S. government is preparing a price floor and tariffs on polysilicon to support domestic factories, with Daqo New Energy cited among the companies expected to be affected. In the updated model, revenue growth was trimmed from about 32.87% to about 30.82%, net profit margin moved from about 1.77% to about 6.50%, the future P/E was cut from about 97.65x to about 23.46x, and the discount rate edged higher from about 12.27% to about 12.37%.
DQ · Capital · Neutral Fair value cut ~18% with JPMorgan Overweight ($22 target) vs Goldman Sell ($10 target) after Q2 non-GAAP net loss on lower ASPs and higher SG&A.
DQ · Tariff · Negative US government preparing a polysilicon price floor and tariffs, with Daqo cited among companies expected to be affected.
688303.CG · Capital · Neutral Parent Daqo New Energy's fair value cut and split analyst ratings (JPMorgan Overweight vs Goldman Sell) after a Q2 net loss.
688303.CG · Tariff · Negative US polysilicon price floor and tariffs cited as affecting Daqo New Energy, the parent of Xinjiang Daqo.
Vor Biopharma's Telitacicept Shows Durable Responses in Phase 3 Myasthenia Gravis Analysis
Vor Biopharma reported a post hoc analysis from a China-based Phase 3 trial showing that telitacicept produced deep, durable clinical responses and was generally well tolerated over 48 weeks in adults with generalized myasthenia gravis. The analysis highlighted that most patients who reached minimal symptom expression maintained it and spent much of their remaining follow-up in this state. The new data reinforce the depth and durability of response but do not materially change the key near-term catalyst, the UPSTREAM global Phase 3 topline readout in 2027, or the central risk that global data might not match prior China experience. The results sit beside Vor's completion of enrollment in the global UPSTREAM Phase 3 gMG trial in early September 2026. Vor Biopharma's narrative projects $111.0 million revenue and $19.1 million earnings by 2029, implying an earnings decrease of $608.7 million from $627.8 million today, and forecasts a $39.00 fair value, a 109% upside to its current price.
Biotech & Genomic Medicine › Autoimmune & Immunology Therapeutics Technology
VOR · Technology · Positive Post hoc Phase 3 analysis shows telitacicept produced deep, durable responses over 48 weeks in generalized myasthenia gravis, reinforcing the drug's clinical profile.
Sanofi, Novartis and Novo Nordisk Lead Week of Multi-Billion-Dollar Healthcare Deals
A Delaware federal judge on Monday rejected requests from Pfizer, BioNTech and Moderna to dismiss lawsuits filed by Bayer's Monsanto unit over their use of US Patent No. 7,741,118, a patent related to mRNA technology, with Judge William Bryson saying the companies failed to prove the patent was invalid or not infringed by their COVID-19 vaccines. Sanofi agreed to a deal worth up to $8B, including $1B upfront, with Regeneron to jointly develop four long-acting immunology therapies, led by the clinical-stage IL-13 monoclonal antibody REGN20423. China's Abogen Biosciences signed a licensing and option agreement with Novartis worth up to $7.8B, comprising a $575 million upfront payment and up to approximately $7.2 billion in potential milestone payments if all options on all programs are exercised, covering an exclusive worldwide license to Abogen's lead asset ABO2203. Jiangsu Hengrui Pharmaceuticals agreed to license global rights to its experimental obesity drug HRS-1596 to Novo Nordisk in a deal worth up to $2.6B, with $300M upfront and the transaction expected to close in Q4 2026. Meanwhile, the S&P 500 Health Care Sector Index slipped 2.66% for the week, with Incyte down 6.93% and Regeneron down 6.71% among the top decliners, while McKesson rose 4.11% and Cardinal Health gained 3.67%.
Hong Kong Q3 share sales hit record $47.5 billion on AI deal boom
Hong Kong share sales raised a record $47.5 billion in the third quarter as Chinese technology companies tapped investors for capital to fund artificial intelligence expansion, Bloomberg reported. Initial public offerings, placements and block trades during the July-to-September period produced the largest fundraising haul ever for those months, pushing the city's total for 2026 above $92 billion and putting Hong Kong within reach of the $112.5 billion annual record set in 2021. Alibaba Group's $10.2 billion follow-on offering was the quarter's largest transaction, while Zhongji Innolight raised almost $8 billion in Hong Kong's biggest listing in nearly seven years. AI model developer Z.AI has raised $9.6 billion this year through its IPO, placements and convertible bonds, and MiniMax, Shanghai Iluvatar CoreX Semiconductor and Shanghai Biren Technology also returned to investors shortly after their IPO lockups expired. The boom spread across Asia-Pacific, where third-quarter share sales exceeded $120 billion, the highest for the period in six years, with India raising a record $26 billion since July on domestic liquidity. Investor appetite is becoming more selective as markets weaken: the MSCI Asia-Pacific Index fell as much as 7% in July amid questions about returns from heavy AI spending, and only two of Hong Kong's 10 largest deals since July are currently trading above their offer prices.
Trip.com Group Beats Estimates as SAMR Penalty Clouds Outlook
Trip.com Group reported quarterly results with earnings per share above analyst estimates, supported by its mix of accommodation, transportation ticketing, and package-tour services across global markets. The beat, according to Simply Wall St, supports the view that Trip.com's technology-driven platforms and expanding international travel offerings are strengthening the resilience and breadth of its business model, though it does not materially change the key near-term catalyst of sustaining international growth. The most relevant recent development alongside the earnings beat is a July 2026 administrative penalty from China's SAMR, which Trip.com has said will prompt governance rectifications, bringing regulatory risk into sharper focus around higher compliance costs and potential limits on high-margin services. Trip.com Group's narrative projects CN¥85.8 billion in revenue and CN¥15.6 billion in earnings by 2029, yielding a $58.45 fair value, a 53% upside to its current price, while bullish analysts assume revenues near CN¥91.8 billion and earnings around CN¥18.8 billion by 2029.
Chinese Online's 2.833 billion yuan private placement plan questioned by Shenzhen Stock Exchange; fundraising scale exceeds net assets by 10 times
Chinese Online announced on the evening of September 30 its largest refinancing plan since listing, planning to issue A-shares to no more than 35 specific investors, with total proceeds not exceeding 2.833 billion yuan, of which 864 million yuan will be used for original literature copyright procurement, the largest single use of the funds. Just two days after the plan was disclosed, the Shenzhen Stock Exchange issued an inquiry letter on October 2, raising questions on five aspects: the use of proceeds, the investment projects, the impact on the company's key financial indicators, the termination of the previous refinancing, and the relationship with its Hong Kong IPO. The company is required to reply in writing and disclose the response before October 8. The inquiry letter pointed out that as of the end of June 2026, Chinese Online had net assets of 263 million yuan, cash and cash equivalents of 277 million yuan, and interest-bearing debt of 428 million yuan. From January to June 2026, net operating cash flow was 127 million yuan, and net profit before and after deducting non-recurring items was negative 43 million yuan and negative 48 million yuan respectively. The Shenzhen Stock Exchange required the company to explain the reasonableness of the financing amount in light of the fact that the fundraising scale is more than 10 times its net assets and the above financial data. The company has not yet disclosed its response to the inquiry letter. In the secondary market, Chinese Online's share price hit an intraday high of 43.80 yuan per share on February 11, 2026, a new high in nearly 10 years, and closed at 23.37 yuan per share on September 30, down 46.63% from the year's high.
300364.CS · Capital · Negative Shenzhen Stock Exchange questions Chinese Online's 2.833 billion yuan private placement, which is over 10 times its net assets, raising financing and valuation concerns.
Fourth round of tire industry price hikes this year takes effect, with all-category products raised by 2% to 5%
Entering October, the fourth round of concentrated price hikes in China's tire industry this year has officially entered its implementation period. Leading tire companies including General Science Technology, Zhongce Rubber, Sailun Tire, and Linglong Tire have raised prices by 2% to 5% across all product categories such as all-steel tires, semi-steel tires, and off-the-road tires. This is already the fourth round of concentrated price-increase notices issued by the tire industry since March this year. In its price adjustment notice, General Science Technology pointed to raw materials as the reason for the increase, saying that prices of natural rubber, synthetic rubber, and carbon black have continued to rise sharply, causing tire manufacturing costs to climb rapidly. Raw materials account for more than 70% of tire production costs, with natural rubber, synthetic rubber, and carbon black together accounting for more than 60%. The simultaneous rise of these three major raw materials is the fundamental driver of this round of price increases. On carbon black, data from SunSirs shows that on October 1, the benchmark price of carbon black was reported at 11,692.86 yuan per ton, up about 59.74% year on year. On natural rubber, as of the end of the third quarter, the main Shanghai rubber futures contract closed above the 20,000 yuan per ton mark, while the average spot price in the domestic market over the same period was about 19,400 yuan per ton, up 31% year on year. On synthetic rubber, according to SunSirs data from October 1, the benchmark price of butadiene rubber was reported at 16,220 yuan per ton, up 39% year on year, and the benchmark price of styrene-butadiene rubber was reported at 16,175 yuan per ton, up about 36% year on year. According to data from Longzhong Information, as of September 29, the raw material cost index for semi-steel tires and the raw material cost index for all-steel tires both rose about 25% year on year. Zhongtai Securities believes that after cost disturbances ease, leading tire companies are expected to return to high year-on-year growth, but industry divergence will further intensify.
601500.CG · Pricing · Positive General Science Technology is a named leader raising prices 2%-5% across all categories, citing raw-material cost inflation
601058.CG · Pricing · Positive Sailun Tire is named among leading tire makers implementing a 2%-5% all-category price hike, lifting its product prices
601966.CG · Pricing · Positive Linglong Tire is named among leading tire companies implementing the 2%-5% all-category price increase
603049.CG · Pricing · Positive Zhongce Rubber is named among leading tire makers raising prices 2%-5% across all product categories
CanSino issues urgent announcement after hitting daily limit up: mRNA cancer vaccine development still in early stage
CanSino surged to the daily limit up on the last trading day before the National Day holiday, with its share price breaking through the previous consolidation range and reaching a new stage high since April 2023, while its H shares also moved higher in tandem. On October 1, CanSino issued a stock movement announcement stating that the company had noted recent market developments regarding mRNA technology, as well as the release or planned disclosure of overseas clinical stage data for mRNA cancer vaccines. CanSino made clear that the mRNA platform is one of the technology platforms in its portfolio, and that the company is developing preventive mRNA vaccines and therapeutic biologics, as well as related delivery systems. In the therapeutic area, it is advancing research and development of mRNA vaccines for indications including glioblastoma, rhabdomyosarcoma, and cervical cancer, as well as the development of In Vivo CAR-related therapies, all of which are currently in early stages. In August this year, Merck and Moderna jointly announced that their personalized messenger RNA cancer vaccine met its primary endpoint in a Phase III trial, making it the first therapeutic vaccine proven effective in a large-scale Phase III clinical trial globally. On August 25, CanSino's official WeChat account announced that its subsidiary CanSino Shanghai Biologics had formally signed a strategic cooperation framework agreement with Depush Hangzhou Biotechnology for the joint development of personalized therapeutic mRNA cancer vaccines. The two parties will jointly advance the research, development, and commercialization of personalized therapeutic mRNA cancer vaccines, with a global focus on gastrointestinal solid tumors and rare tumor treatment areas. It should be noted that CanSino's entire mRNA product line has not yet moved beyond the early research and development stage, and innovative drug development carries multiple uncertainties including technical failure, clinical results falling short of expectations, and approval delays, while competition in the domestic mRNA vaccine sector is also becoming increasingly intense.
688185.CG · Technology · Neutral CanSino clarified its mRNA cancer vaccine programs (glioblastoma, rhabdomyosarcoma, cervical cancer, In Vivo CAR) remain in early stages despite the stock's limit-up.
德普世(杭州)生物科技有限责任公司 · Demand · Positive Depush Hangzhou signed a strategic cooperation framework agreement with CanSino Shanghai Biologics to jointly develop personalized therapeutic mRNA cancer vaccines.
MRK · Technology · Positive Merck's partnered personalized mRNA cancer vaccine met its primary endpoint in a Phase III trial, the first such therapeutic vaccine success.
MRNA · Technology · Positive Moderna's jointly announced personalized mRNA cancer vaccine met its primary endpoint in a Phase III trial.
Chuangyao Technology Earnings Call Responds to SparkLink 2.0 and M&A Questions; First-Half Revenue and Net Profit Both Decline
Chuangyao Technology held its 2026 semi-annual earnings briefing on September 29 via the Shanghai Stock Exchange's SSE Roadshow Center, responding to investor questions on SparkLink 2.0 tape-out and M&A progress. In the first half of 2026, the company achieved operating revenue of 167 million yuan, down 9.02% year-on-year; net profit attributable to the parent was 11.7539 million yuan, plunging 63.16% year-on-year; non-GAAP net profit swung from 26.7156 million yuan in the same period last year to a loss of 2.7683 million yuan, a decline of 110.36%, which the company said was mainly due to a year-on-year increase in government subsidies during the period. Gross margin fell to 28.00% in the first half, down 3.28 percentage points year-on-year, and net margin was only 7.05%, down 10.36 percentage points from the same period last year; net cash flow from operating activities was 45.7005 million yuan, surging 181.95% year-on-year, but the company admitted this was mainly due to an increase in deposit interest actually received. In the second quarter, the company achieved operating revenue of 96.1239 million yuan, up 36.23% quarter-on-quarter, but net profit attributable to the parent was only 1.368 million yuan, down 93.2% year-on-year and down 86.83% quarter-on-quarter. The company confirmed that SparkLink 2.0 has been initiated and is under continuous R&D investment, with the protocol standard adding a network layer and featuring ranging and positioning as well as integrated sensing and communication functions, but regarding when tape-out and shipment will occur and when mass production will begin, it only said to refer to company announcements; EtherCAT slave controller chips have achieved sales to customers in industrial, medical, semiconductor and other fields, and have entered the domestic mainstream embodied robot industry chain, but related revenue still accounts for a relatively low proportion. On M&A progress, the company responded that its investment and M&A layout is advancing steadily, and it will actively yet prudently promote external expansion under strict risk control. As of September 30, the company's stock price closed at 31.99 yuan per share, down more than 50% from the issue price of 66.6 yuan per share, and remains below the issue price.
China Skips Soybean Tariff Cut, Disappointing US Farmers
China did not signal any plan to lower tariffs on US soybeans following last month's US-China summit. Soybeans were not included in the list of goods worth 30 billion dollars targeted for tariff reductions that the two governments published after the meeting, and the American Soybean Association, a producers' group, made no secret of its disappointment. China is the largest export destination for US soybeans, but intensifying trade war has cost US producers market share to Brazilian supplies, and with the additional 10 percent tariff still in place, Chinese private buyers may keep hesitating to purchase. China indicated it intends to lower tariffs on US corn and wheat, but demand is seen as limited, and Nippon's chief grain analyst Hideki Hattori analyzes that China likely wants to hold soybeans in reserve as a bargaining chip in future negotiations with the United States. In the United States, now in harvest season, diesel prices have surged amid turmoil in the Middle East, and according to AAA, the average price as of the 2nd was about 6.37 dollars per gallon, up roughly 70 percent from a year earlier, prompting American Farm Bureau Federation President Zippy Duvall to ask President Trump for support including a cut in the diesel tax.
SOYBEAN · Tariff · Negative China left the 10% tariff on US soybeans in place and excluded them from the $30B tariff-cut list, keeping Chinese buyers hesitant and pressuring US soybean demand.
Porsche Bets on Gas Engines as EV Sales and China Deliveries Slump
Porsche is betting that a return to gas-powered vehicles will drive its turnaround, but the pivot may not be enough to fill a costly near-term gap. CEO Michael Leiters, in place since January, plans to bring back a combustion-engine Macan to sell alongside the electric version, though not until 2028, after the outgoing gas Macan's production was slated to end in July. Electric Macan sales dropped 40% in the first half of 2026 and Taycan EV deliveries fell 25%, while the 911 was the only model line to grow, up 19%. HSBC estimates the timing gap will cost Porsche around 25,000 units and roughly €500 million ($563 million) in profit in 2027, and forecasts operating profit will fall 8% that year. China deliveries sank 32% in the first half to around 14,500 units, extending a four-year decline, and first-half revenue fell 5% to 17.23 billion euros ($19.4 billion) even as operating profit rose 34% to 1.35 billion euros ($1.5 billion). On Sept. 18, Volkswagen said it would take a non-cash impairment of around 6 billion euros ($6.8 billion) on goodwill tied to Porsche, and investors will hear more on Oct. 7 at Porsche's capital markets day.
P911.XETRA · Capital · Negative HSBC estimates the combustion-Macan timing gap will cost ~25,000 units and ~€500M profit in 2027, with operating profit forecast to fall 8%.
P911.XETRA · Demand · Negative Electric Macan sales fell 40% and Taycan deliveries dropped 25%, with China deliveries down 32%, driving the gas-engine pivot.
VOW.XETRA · Capital · Negative Volkswagen takes a ~€6B non-cash goodwill impairment tied to Porsche.
VOW3.XETRA · Capital · Negative Volkswagen takes a ~€6B non-cash goodwill impairment tied to Porsche.
PAH3.XETRA · Capital · Negative As Porsche's controlling shareholder, it is exposed to the ~€6B Volkswagen goodwill impairment tied to Porsche and Porsche's profit decline.
BTIG: Half-Size Robots Dominate Humanoid Shipments, Only 32% Full-Size
BTIG analyst Jesse Sobelson said the humanoid robot industry has split into two largely separate product classes, with half-size systems, mostly Chinese, measuring roughly 94–138 cm and weighing 12–40 kg, and full-size machines generally standing 165–190 cm tall and weighing 47–90 kg. BTIG estimates that major players Unitree and AgiBot had built approximately 31K humanoids through June, of which only about 9.8K, or 32%, were full-size units of any type, and full-size bipeds represented only about 13% of cumulative production. Sobelson warned that industry shipment figures can be misleading if interpreted as evidence of broad adoption of human-scale robotic labor, since many of the estimated +40K cumulative shipments through mid-2026 were smaller, lower-cost Chinese units rather than industrial-grade humanoid bipeds. Hangzhou-based Unitree's smaller R1 and G1 products are priced approximately from $4,900 to $21,500 depending on configuration, and BTIG expects Unitree's 2026 shipments to at least double from around 6,000 in 2025, while the company plans for an annual capacity of 30K units. Tesla is the major potential challenger to the current half-size dominance, with BTIG saying Tesla anticipated Optimus production at Fremont later in 2026 but warned that initial output would be slow because the new line includes about 10K unique parts; Sobelson views Tesla, along with Figure, 1X, and Boston Dynamics, as the key players if there is to be a future shift toward full-size systems.
688836.CG · Demand · Positive BTIG estimates Unitree built ~31K humanoids with 2026 shipments to at least double from ~6,000 in 2025, and plans 30K annual capacity.
智元机器人 · Demand · Positive BTIG estimates AgiBot (智元机器人) is a major player in the half-size humanoid build, contributing to the ~31K cumulative units through June.
TSLA · Technology · Neutral BTIG says Tesla is the key potential challenger to half-size dominance, with Optimus production anticipated at Fremont later in 2026 but slow initial output due to ~10K unique parts.
1X Technologies · Technology · Neutral 1X Technologies is mentioned only as a key player for a potential future shift to full-size systems, with no concrete development.
Boston Dynamics · Technology · Neutral Boston Dynamics is named only as one of the key players if the industry shifts toward full-size systems, with no specific development.
China launches anti-dumping probe into EU chemicals as trade friction widens
China's Ministry of Commerce announced on the 3rd that it has launched an anti-dumping investigation into para-nitrotoluene, a chemical used as a raw material for pharmaceuticals and pesticides, targeting imports from the European Union. It claims that import prices from the EU fell by about 60 percent between 2022 and 2025, potentially harming China's domestic industry. The move is seen as a countermeasure against the EU, which has been tightening regulations on China, and trade friction with Europe is widening.
Betaini's first self-developed medical aesthetic injectable BTN001 approved, first interim dividend launched simultaneously
Betaini's self-developed injectable sodium hyaluronate solution BTN001 has officially received approval from the National Medical Products Administration, obtaining a Class III medical device registration certificate with registration number 20263131919. This is the group's first self-developed Class III medical device approved for market. Institutional research reports note that Betaini, leveraging its Winona sensitive-skin base and Acoman clinical channel, uses BTN001 to close the loop of pre-operative stabilization, intra-operative injection, and post-operative repair, strengthening its full-cycle medical aesthetic service capability. The new product is restricted to medical institutions, with high barriers and large pricing space, and is expected to open a second growth curve. In terms of shareholder returns, as of August 31, 2026, the company had cumulatively repurchased 3.6997 million shares, accounting for 0.8734% of total share capital, with a total transaction amount of approximately 120 million yuan. At the same time, it launched its first interim dividend, proposing a cash dividend of 1.50 yuan per 10 shares to all shareholders, with an estimated total payout of approximately 62.639 million yuan. Controlling shareholder Guo Zhenyu also pledged in April this year not to reduce his holdings within 12 months. In the first half of 2026, Betaini achieved operating revenue of 2.592 billion yuan, up 9.27% year-on-year, net profit attributable to the parent of 292 million yuan, up 18.30% year-on-year, and non-GAAP net profit attributable to the parent of 246 million yuan, a sharp increase of 34.85% year-on-year. Net cash flow from operating activities was 394 million yuan, up 13.53% year-on-year. Gross margin reached 74.62%, and the selling expense ratio fell 3.64 percentage points year-on-year to 50.53%. However, Betaini's share price has fallen about 15% cumulatively this year, hovering around 30 to 35 yuan from late June to late September. As of September 30, it closed at 32.70 yuan per share, with a latest total market value of approximately 13.8 billion yuan.
300957.CS · Capital · Positive Company launched its first interim dividend of 1.50 yuan per 10 shares and had cumulatively repurchased 3.6997 million shares for ~120 million yuan.
300957.CS · Technology · Positive Betaini's first self-developed Class III medical device BTN001 (sodium hyaluronate injectable) received NMPA approval, opening a second growth curve.
Guangda Special Materials Earnings Call Addresses Employee Stock Ownership and AI Applications
Guangda Special Materials held its 2026 semi-annual earnings briefing online on September 30, responding to questions about artificial intelligence applications, the employee stock ownership plan, product expansion, and raw material price fluctuations. The company's 2026 semi-annual report shows operating revenue of 2.323 billion yuan, down 8.36 percent year on year; net profit attributable to the parent company of 12.34 million yuan, down 93.33 percent; non-GAAP net profit attributable to the parent company of 11.32 million yuan, down 93.67 percent; net operating cash flow of negative 231 million yuan; and a main business gross margin of 13.37 percent, down 7.31 percentage points from the same period last year, mainly affected by reduced new installed capacity in the downstream wind power industry. Regarding the progress of the employee stock ownership plan that investors are concerned about, the company responded that within six months after approval by the shareholders' meeting, the management committee of the employee stock ownership plan will complete the purchase of underlying shares through methods such as buying the company's A-shares on the secondary market, and the company will complete the position building gradually during the building period based on market conditions. On artificial intelligence, the company said the relevant applications are still in the evaluation and testing stage, have not formed large-scale applications, and have no material impact on company performance. In terms of product expansion, the company has passed the international aerospace quality management system certification AS9100D, and its production technology for high-purity superalloy electroslag ingots has been applied in fields such as aircraft engines and gas turbines. Homogeneous fine-grained superalloy forgings have been supplied in batches to aircraft engines, rocket engines, and gas turbines. The aerospace superalloy UNS N07041 has achieved batch supply, and the company has carried out cooperation with relevant customers in the aerospace field and achieved batch supply.
Huichuangda Plans Cash Acquisition of 100% Equity in Chuncao Technology
A-share consumer electronics concept stock Huichuangda announced that it plans to acquire 100% equity in Dongguan Chuncao Grinding Technology Co., Ltd., known as Chuncao Technology, through a combination of direct and indirect acquisitions in cash. Upon completion of the transaction, Chuncao Technology will become a wholly-owned subsidiary of Huichuangda and be included in its consolidated financial statements. Huichuangda's main business is the research, development, design, production and sales of light guide structural components and assemblies, and precision key switch structural components and assemblies, with products applied in consumer electronics, automotive electronics, new energy and other fields. Chuncao Technology is a systematic service provider specializing in grinding and polishing intelligent surface treatment equipment, automated production lines and polishing consumables. It has become a qualified supplier to many leading companies in 3C, automotive parts and other fields, with well-known customers including Foxconn, Lens Technology, Luxshare Precision, Biel Crystal, BYD, Jingyan Technology and Gengde Electronics. In the secondary market, Huichuangda's share price has recently fluctuated upward. As of the close on September 30, Huichuangda fell 8.22% on the day to close at 60.97 yuan per share, with a total market value of 10.5 billion yuan.
300909.CS · Capital · Positive Huichuangda plans a cash acquisition of 100% equity in Chuncao Technology, which will become a wholly-owned consolidated subsidiary.
东莞市春草研磨科技有限公司 · Capital · Positive Chuncao Technology is being fully acquired by Huichuangda in cash, becoming its wholly-owned subsidiary.
Morgan Stanley Cuts Nike Price Target to 27 on Inventory Glut
Morgan Stanley cut its Nike price target to 27 from 31, with analyst Alex Straton saying the company's first quarter is likely this year's high watermark rather than the low. Straton, who went underweight on the stock late last year, said Nike's guidance embeds a high single digit sales decline and that reaching full-year targets requires both top-line and earnings trends to degrade from here. She attributed the pressure to excess inventory in North America and a similar dynamic in China, the two biggest sportswear markets in the world, compounded by a challenging macro backdrop. Straton flagged three problem areas for the company: Sportswear, which makes up almost two-thirds of the portfolio and roughly 30 billion dollars in revenue, the Jordan brand, and a material change in the China outlook. She said she has not seen the bottom in negative revisions and that Nike may face a shrink-to-grow story, with further de-rating possible if the company settles into a lower-growth, lower-margin multiple. Nike holds an investor day in November, where Straton said the company needs to clarify the right revenue size for Sportswear, Jordan and China before investors can gauge when growth and historical margins might return.
NKE · Capital · Negative Morgan Stanley cut Nike's price target to 27 from 31, citing embedded high-single-digit sales declines and further de-rating risk.
NKE · Supply · Negative Excess inventory in North America and a similar dynamic in China are pressuring Nike's outlook.
MS · Capital · Neutral Morgan Stanley is the analyst firm cutting Nike's price target, an action about Nike rather than a development affecting Morgan Stanley itself.
Nike Shares Fall 5.5% After Weak Guidance and 4% Sales Decline
Nike shares fell 5.5% in the morning session after the athletic apparel brand reported a 4% sales decline and issued weaker-than-expected full-year profit guidance. The company guided fiscal 2027 revenues to decline by high single digits and estimated adjusted diluted earnings per share between $1.15 and $1.35, missing analyst expectations of $1.68 per share amid product challenges and an ailing China business. For calendar Q3 2026, which is fiscal Q1 2027, sales fell 4.3% year on year to $11.21 billion, short of revenue expectations, while GAAP profit of $0.48 per share came in 9.9% above analysts' consensus estimates and gross margin expanded 60 basis points to 42.8% on lower logistics costs. Chief Financial Officer Dave Denton warned on the call that China's revenue will worsen for the balance of the year as Nike cleans up promotional distribution, and Chief Executive Officer Elliott Hill said deliberately reducing Dunk production by nearly half created a roughly $200 million headwind in Sportswear. Denton also noted that the bulk of savings from the Pace operating model transformation, which targets approximately $2.5 billion in cumulative savings through fiscal 2031, will not ramp until fiscal 2029 and 2030.
NKE · Capital · Negative Nike issued weaker-than-expected FY2027 guidance with adjusted EPS of $1.15-$1.35 versus $1.68 consensus and high-single-digit revenue decline.
NKE · Demand · Negative Nike reported a 4.3% year-on-year sales decline to $11.21 billion, missing revenue expectations amid product challenges and an ailing China business.
Nike Cuts Jobs and Overhauls Business as Slump Deepens
Nike Inc. is cutting jobs and embarking on a sweeping overhaul of the business as results deteriorate and test Wall Street's patience with Chief Executive Officer Elliott Hill. Sportswear, roughly 50% of Nike's business, is still down, Jordan is down, and China plunged 26% in the latest quarter, according to Bloomberg Intelligence senior US e-commerce and retail analyst Poonam Goyal. Goyal credited Hill with fixing North America and the performance business, which grew high single digits in the latest fiscal quarter, but said the turnaround will take more than 12 months and that investors will hear more at the analyst meeting in November. Nike already has a 2.5 billion dollar cost-savings plan in place that carries 1 billion dollars in restructuring costs, she said, adding that the remaining problem is product-led. Jordan, which Goyal said is 13% of Nike's sales and a 7 billion dollar business, suffered from flooding the marketplace with retro product, eroding the exclusivity, selection and scarcity that make the brand work.
NKE · Capital · Negative Nike is cutting jobs and overhauling the business as results deteriorate, with a $2.5B cost-savings plan carrying $1B in restructuring costs.
NKE · Demand · Negative Sportswear and Jordan sales are down and China plunged 26% in the latest quarter, with the remaining problem described as product-led.
Nike Shares Hit Multi-Year Lows Near $32 After Q1 Revenue Miss
Nike shares have fallen to multi-year lows near $32 after the company's fiscal first-quarter results showed an earnings beat driven by margins but an $11.2 billion revenue haul that was over 4% lower than a year earlier. Analysts have continued cutting estimates and price targets, with the consensus EPS estimate for full-year FY 2027, which ends in May, dropping from $1.67 to $1.61, representing annual growth of just 1.9%. On the earnings call, CEO Elliott Hill said the company is prioritizing marketplace health over near-term volume, noting that performance categories are gaining traction while Sportswear, Jordan Brand and Greater China remain under pressure. CFO David Denton introduced a clearer financial framework including full-year guidance and a multiyear cost program, while warning that restructuring pressure will extend into fiscal 2028. The article was originally published on Zacks Investment Research.
iQIYI AIGC Film Series The Ferry Man Tops RMB 8 Million in Revenue-Sharing
iQIYI announced that cumulative revenue-sharing for its AIGC film series The Ferry Man has surpassed RMB 8 million, or US$1.2 million, as of September 23, as the third instalment, The Ferry Man: The Dream of the Princess, debuts on October 1 on iQIYI and iQIYI International. Produced by iQIYI and GHY Culture & Media, the series' first two titles, The Ferry Man: Butterfly Dream and The Ferry Man: The Dream of the Celestial Maiden, were released simultaneously on August 22 and recovered their full production costs within the first week, surpassing RMB 8 million in cumulative box office within the first month. Producer Zhichao LI said the first two films moved from project initiation to launch in less than four months, with AI improving efficiency during preparation and production while script development and post-production stayed largely consistent with traditional workflows. The series builds lasting digital asset value through AIGC, with the three lead actors licensing their likenesses and providing their own voiceovers, and standardized reusable digital character, scene and prop assets that let the third film maintain visual consistency while cutting production costs. The release follows iQIYI's earlier long-form AIGC effort, Mystic Tales - The Spider Lady's Vendetta, which the company describes as China's first AIGC internet feature film released under an Internet Drama and Film Distribution License.
Artificial Intelligence › AI Applications & Copilots ▲Technology
IQ · Demand · Positive iQIYI's AIGC film series The Ferry Man surpassed RMB 8 million in revenue-sharing, with the first two titles recovering full production costs within a week.
GHY Culture & Media · Demand · Positive Co-produced iQIYI's AIGC film series The Ferry Man, which surpassed RMB 8 million in revenue-sharing and recovered production costs.
Volkswagen sustainability chief says China's EV rise demands adaptation, not tariffs
Volkswagen's chief sustainability officer Dirk Voeste said Europe's automakers must adapt to Chinese competition rather than try to preserve the old industrial model with tariffs or slogans. Volkswagen's deliveries in China fell 36.6% in the second quarter, and a company spokesperson told Fortune the Chinese automotive market has declined by 20% year-over-year, with Volkswagen's share down 26%, though the company remains the leader in combustion-engine vehicles with a market share over 22%. Volkswagen expects the overall Chinese market for new vehicles to decline to below 21 million vehicles this year and said Volkswagen Group China cannot escape the trend and is adjusting its plans accordingly. Voeste, who joined Volkswagen in 2023 after 22 years at BASF, described the company's Regenerate+ sustainability framework, built with more than 100 employees rather than an outside consultancy, and said the circular economy around remanufacturing, refurbishment, used parts and material reuse is really a new profit pool. He said his daughter's challenge to clean up the mess his generation left became a private mission statement, and argued that companies and economies that endure will be those that change before outside pressure forces them to.
Black Lake founder Zhou Yuxiang bets on factory-floor AI with PopZao platform
Black Lake Technologies founder Zhou Yuxiang is betting that the most interesting market for AI is the factory floor, not the consumer smartphone or the corporate office. The Shanghai-based startup sells cloud-based factory-management software that tracks orders, schedules, materials and output, plus AI agents that can read an incoming order, generate a quote and schedule production on their own; Black Lake says it has been profitable since 2025 and that revenue has grown more than 60% a year. Zhou, a Dartmouth graduate and former investment banker, recruited his sales team from food delivery riders at Meituan and Alibaba's Ele.me after salespeople hired from SAP and Siemens failed to get past factory security guards, putting new hires through a five-day "devil boot camp" of 14-hour training sessions from which only about half graduated. His new platform, PopZao, a website and WeChat mini program incubated for two years, aims to connect China's factories with its creator economy, with Black Lake's agents converting ideas into designs, 3D simulations and industrial data sent to a factory; one early customer, a Buddhist temple, sold out a batch of 500 units in a week after a 30-day turnaround. Zhou said AI has not yet reached its "Google moment" because it is only replacing tasks rather than restructuring industries, and he pointed to China's digitization gap, noting that the concept only became recognized by factory owners about 10 years ago, while Western countries spent 40 to 50 years on it.
Artificial Intelligence › AI Applications & Copilots ▲Technology
Artificial Intelligence › Agentic AI & Autonomous Workflows ▲Technology
Black Lake Technologies · Demand · Positive Black Lake's PopZao platform connects factories with the creator economy, with an early customer selling out 500 units, signaling real product adoption.
Goldman Sachs Names CATL and Zenergy Top China Battery Picks
Goldman Sachs has identified Contemporary Amperex Technology Co and Jiangsu Zenergy Battery Technologies Group as its top picks in China's battery sector. CATL, the world's largest battery manufacturer, ranks first on leading scale, battery technology and cost competitiveness, with Goldman Sachs setting a 12-month price target of HK$947 for its H-shares and RMB565 for its A-shares under a sum-of-the-parts valuation. The bank points to CATL's shift from cells to integrated energy solutions as a key value driver, supporting share consolidation, higher project value capture, recurring service revenue and stronger margins. Zenergy takes second place as an underappreciated high-growth EV battery platform founded in 2019, benefiting from auto-component expertise inherited from Fuyao Glass and described by Goldman Sachs as the fastest EBITDA growth in its coverage universe. The bank maintains a Buy rating on Zenergy with a price target of HK$9, noting it trades at a significant discount to peers. Risks cited for both names include slower-than-expected EV and energy storage demand, rising raw material costs and intensifying competition.